- Home
- SNT vs PRPO Comparison
SNT vs PRPO Comparison
Compare SNT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNT | PRPO |
|---|---|---|
| Founded | 1965 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 38.3M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SNT | PRPO |
|---|---|---|
| Price | $1.34 | $21.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.4K | ★ 45.3K |
| Earning Date | 11-24-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $24,049,000.00 |
| Revenue This Year | N/A | $233.72 |
| Revenue Next Year | N/A | $22.61 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 29.77 |
| 52 Week Low | $1.40 | $18.50 |
| 52 Week High | $5.10 | $33.63 |
Technical Indicators
Market Signals| Indicator | SNT | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 29.88 | 30.83 |
| Support Level | N/A | $19.37 |
| Resistance Level | $1.63 | $24.78 |
| Average True Range (ATR) | 0.08 | 0.98 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 8.33 | 3.69 |
Price Performance
Historical ComparisonAbout SNT Senstar Technologies Ltd.
Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.
About PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.